BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK AND BRISTOL MYERS SQUIBB
More Q3 Earnings From Big Pharma Giants Top Wall Street Expectations Following… Read More
© 2025 CSRXP- All Rights Reserved
BIG PHARMA WATCH: ONCOLOGISTS WHO RECEIVED BIG PHARMA KICKBACKS WERE MORE LIKELY TO PRESCRIBE HIGHER PRICED AND LESS EFFECTIVE DRUGS
Research Exposes How Big Pharma’s Self-Serving Kickbacks Increase Costs and… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times… Read More
BIG PHARMA WATCH: PFIZER TO RAISE PRICE ON COVID-19 TREATMENT NEARLY 300 PERCENT
Big Pharma Giant Increases Paxlovid Price Weeks After Making Price Hike on… Read More
BIG PHARMA WATCH: KICKBACKS INCREASED SPENDING ON HIGH PRICED AGE-RELATED MACULAR DEGENERATION DRUGS BY $642.8 MILLION OVER SIX YEARS
Eye Doctors Who Accepted Big Pharma Payments Were More Likely to Prescribe… Read More
FACT SHEET: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS, TAXPAYERS AND THE U.S. HEALTH CARE SYSTEM BILLIONS OF DOLLARS
Big Pharma’s Anti-Competitive Tactics Are The Root Cause of Out-of-Control… Read More
Big Pharma Watch: Study Finds Patent Thickets on Just Four Drugs Extended Monopolies By a Combined 25 Years
I-MAK Analysis Reveals Patent Abuse on Four Blockbuster Medications Generated… Read More
DOSE OF REALITY: BIG PHARMA’S TWO DECADES OF PRICE HIKES AND ADVERTISING BINGING ON TEN DRUGS ELIGIBLE FOR MEDICARE NEGOTIATION
A History of Big Pharma’s Egregious Pricing Practices and Billions of… Read More
SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
Brand Name Drug Companies Claim Lowering Rx Prices Will Undercut R&D —… Read More
CSRXP: BIG PHARMA MAKES EGREGIOUS VACCINE PRICES HIKES OFFICIAL
Pfizer and Moderna Raise Prices on Vaccines After Years of Taxpayer… Read More
CSRxP: Weight Loss Drugs the Latest Target for Big Pharma’s Price-Gouging of American Patients
Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity… Read More
BIG PHARMA WATCH: LIST PRICES ON TOP 25 MEDICARE PART D DRUGS MORE THAN TRIPLED SINCE COMING TO MARKET
AARP Analysis Finds Prices for Best-Selling Medicare Part D Drugs Rose 226… Read More